Mirae Asset, Yuanta Selected as Co-managers of 500 bln-won K-Bio Vaccine Fund
SEOUL, Sept. 28 (Korea Bizwire) — Mirae Asset Venture Investment Co. and Yuanta Investment Co. have been selected as co-managers of a 500 billion-won (US$346 million) state bio fund aimed at supporting domestic pharmaceutical companies’ development of innovative medicine and entrance to the global market, the health ministry said Wednesday. The equity firms have been [...]